Reducing Lead Time & Optimizing Costs
Because of competitive pressures, generic manufacturers are under considerable influence to get their products to market quickly. To meet increasing quality standards and ensure a quick move to market, emerging generics injectable manufacturers needed flexibility and simplicity when dealing with drug containment and delivery.
AccelTRA's component program can provide robust extractables data and optimize lead times for both samples and commercial quantities. Explore how the use of this component platform – including components, extractables data and collaboration with our technical experts – helped us realize significant savings, reduce elastomer SKU complexity, and increase speed to market.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.